Inflammation and metastases

Medical Hypotheses

Volumn 47, Issue 3, 1996, Pages 193-196

  Nowacki, M P ^a   Janik, P ^a   Nowacki, P M ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ANTINEOPLASTIC ACTIVITY; DRUG EFFECT; HUMAN; INFLAMMATION; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0029841385     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90080-8     Document Type: Article

References (47)

1. Lamerton L F. Tumor cell kinetics. Br Med Bull 1973; 29: 23-49.
2. Steel G G. Cell loss as a factor in the growth rate of human tumors. Eur J Cancer 1967; 3: 381-387.
3. Fidler I J, Hart I R. Biological diversity in metastatic neoplasm. Origin and application. Science 1982; 217: 998-1003.
4. Nicolson G I. Cancer metastasis: tumor cell and organ properties important in metastasis to specific secondary sites. Bioch Bioph Acta 1988; 948: 175-224.
5. Honn K V, Grossi I M, Diglio C A, Wojtukiewicz M. The lipooxygenase metabolite 12-(S)-HETE induces endothelial cell retraction resulting in enhancement of tumor cell adhesion to subendothelial matrix. FASEB J 1989; 3: 2285-2293.
6. Honn K V, Steinert B W, Onoda J M, Taylor J D. The role of tumor cell induced platelets aggregation. Bioch Biophys Res Commun 1987; 145: 384-389.
7. Harlam J M. Leukocyte-endothelial interaction. Blood 1985; 65: 513-518.
8. Orr F W, Warner D J A. Effects of neutrophil-mediated pulmonary endothelial injury on the localization and metastasis of circulating Walker carcinoma cells. Invasion and Metastasis 1985; 7: 183-196.
9. Pollard M, Lucker P M. Treatment of chemically induced intestinal cancer with indomethacin. Proc Soc Exp Biol Med 1981; 167: 161-164.
10. Pollard M, Lucker P M. Effect of indomethacin on intestinal tumors induced in rats by acetate derivative of dimethylnitrosoamine. Science 1981; 214: 558-559.
11. Salim A S. Removing oxygen-derived free radicals delays metastases and prolongs survival in colonic cancer. Study in the rat. Oncology 1992; 49: 58-62.
12. Dvorak H F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New Engl J Med 1986; 315: 1650-1659.
13. Dingemans K P, Zeeman-Boeschoten I M, Keep R F, Das P K. Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. Int J Cancer 1993; 54: 1010-1016.
14. Brenk van der H A S, Orton C, Sharpington C. Stimulation of clonogenic growth of tumor cells and metastases in the lungs by local x-ray radiation. Br J Cancer 1973; 27: 291-306.
15. Janik P. Lung colony assay in normal, irradiated and tumor bearing mice. Neoplasma 1976; 23: 495-497.
16. Withers H R, Milas L. Influence of preirradiation of lung on development of artificial pulmonary metastases. Cancer Res 1973; 33: 1931-1936.
17. Metzer U, Meier J, Uhlschmid G, Weihe H. Influence of various prostaglandin synthesis inhibitor on DMH-induced rat colon cancer. Dis Colon Rectum 1984; 27: 366-369.
18. Reddy P, Muruyama H, Kellof G. Dose related inhibition of colon carcinogenesis by dietary piroxicam, a non-steroidal anti-inflammatory drug during different stages of rat tumor development. Cancer Res 1987; 47: 5340-5346.
19. Reddy B S, Rao C V, Rivenson A, Kelloff G. Inhibitory effects of aspirin on azoxy methane-induced colon carcinogenesis in F344 rats. Carcinogenesis 1993; 14: 1493-1497.
20. Kudo T, Narisawa T, Abo S. Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. Gann 1980; 71: 260-264.
21. Waddell W R, Ganser G F, Cerise E J, Loughry R W. Sulindac for polyposis of colon. Am J Surg 1989; 157: 175-179.
22. Rigau J, Pique J M, Rubio E, Planas R, Tarrech J M, Bordas J M. Effect of long term sulindac therapy on colonic polyposis. Ann Intern Med 1991; 115: 952-954.
23. Giardiello F M, Hamilton S R, Krush A J et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313-1316.
24. Nugent K P, Farmer K C R, Spigelman A D, Williams C B, Phillips R K S. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993; 89: 1618-1619.
25. Winde G, Schmid K W, Schlegel W, Fischer R, Osswald H, Bunte H. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Dis Colon Rectum 1995; 38: 813-830.
26. Baron J A, Greenberg E W. Could aspirin really prevent colon cancer? N Engl J Med 1991; 325: 1664-1645.
27. Thun M J, Namboodiri B S, Heath C W. Aspirin use reduces risk of fatal colon cancer. N Engl J Med 1991; 32: 1593-1596.
28. Logan R F A, Little J, Hawtin P G, Hardcastle JD. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. BMJ 1993; 307: 285-289.
29. Greenberg E R, Baron J A, Freeman D H Jr, Mandel J S, Haile R. Reduced risk of large bowel adenomas among aspirin users. J Natl Cancer Inst 1993 ; 85: 912-916.
30. Kune G A, Kune S, Watson L F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Res 1988; 48: 4399-4404.
31. Rosenberg L, Palmer J R, Zauber A G, Warshauer M E, Stolley P D, Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst 1991; 83: 355-358.
32. Peleg I I, Maibach H T, Brown S H, Wilcox C M. Aspirin and non-steroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 1994; 154: 394-399.
33. Lundholm K, Gelin J, Hyltander C et al. Anti-inflammatory treatment may prolonge survival in undernourished patients with metastatic solid tumors. Cancer Res 1994; 54: 5602-5606.
34. Nowacki M P, Szymendera J J. The strongest prognostic factors in colorectal carcinoma. Surgicopathologic stage of disease and postoperative fever. Dis Colon Rectum 1983; 26: 263-268.
35. Chazelet C, Baumel H, Deixone B, Daures J M, Saisi G. Les facteurs prognostiques des cancer du colon droit opérés. Analyse multifactoriele d'une serie de 50 exerèses a visée curative. J Chir (Paris) 1989; 126: 81-84.
36. Teucher G, Schindler A E. Postoperatives Fieber und Prognoses des Mammakarzinoms. Arch Geschwulstforschung 1987; 4: 309-317.
37. Ruka W. Istotne czynniki rokownicze w miesakach tkanek miekkich o wysokiej zlosliwosci histologicznej. DSc thesis. Cancer Center Warsaw, 1988.
38. Hannisdal E, Thorsen G. Regression analysis of prognostic factors in colorectal cancer. J Surg Oncol 1988; 26: 263-268.
39. McMillan D C, Wotherspoon H A, Fearon K C H et al. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995; 170: 319-332.
40. Brooks P M, Day R O. Non-steroidal anti-inflammatory drugs, deferences and similarities. N Engl J Med 1991; 324: 1716-1725.
41. Heath C W, Thun M J, Greenberg E R, Levin B, Marnett L J. Nonsteroidal anti-inflammatory drugs and human cancer. Report of an interdisciplinary research workshop. Cancer 1994; 74: 2885-2888.
42. Cerutti P A. Mechanisms of action of oxidant carcinogenesis. Cancer Detection and Prevention 1989; 14: 281-284.
43. Herbenhahn M, Kloz U, Tremp G L, Hecker E. Toxodynamics of tumor promotors of mouse skin. II. Binding to protein kinase C of some new diterpen esters and induction of luminol-enhanced chemiluminescence in mouse peritoneal neutrophils. J Cancer Res Clin Oncol 1991; 117: 385-395.
44. Brennen S S, Foster M E, Morgan A et al. Prostaglandins in colonic anastomosis healing. Dis Colon Rectum 1984; 27: 723-725.
45. Mathes S J, Abouljoud M. Wound healing. In: Davis J H, ed. Clinical Surgery. St Louis, MI: C V Mosby, 1987: 489.
46. McEvoy G K, ed. Indomethacin. In: American Hospital Formulatory Service Drug Information. Bethesda, MD: Am Soc Hosp Pharm 1988: 1007-1017.
47. Bernhard G C. Worldwide experience with nabumetone. J Rheum 1992; 19(s36): 48-57.